Professional
Added to YB: 2025-10-24
Pitch date: 2025-10-21
MEDP [neutral]
Medpace Holdings, Inc.
+2.83%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Market Cap
$15.4B
Pitch Price
$543.38
Price Target
N/A
Dividend
N/A
EV/EBITDA
26.28
P/E
38.18
EV/Sales
6.44
Sector
Life Sciences Tools and Services
Category
growth
The Optimist Fund Portfolio Holding: Medpace Holdings, Inc.
MEDP (holding update): Market-leading CRO w/ founder/CEO that is showing strong inflection after 6 quarters of slowing growth. Q2 rev +14.2% to $603M, net income $90M ($3.10/share), EBITDA +16.2% to $130M (21.6% margin). Aggressive $518M buyback of 1.75M shares. 2025 guidance raised: $2.42-2.52B rev, $405-428M net income.
Read full article (1 min)